140 related articles for article (PubMed ID: 38708447)
1. A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function.
Navarro E; Esteras N
FEBS J; 2024 Jun; 291(12):2562-2564. PubMed ID: 38708447
[TBL] [Abstract][Full Text] [Related]
2. Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria.
Al Rawi S; Simpson L; Agnarsdóttir G; McDonald NQ; Chernuha V; Elpeleg O; Zeviani M; Barker RA; Spiegel R; Laman H
FEBS J; 2024 Jun; 291(12):2565-2589. PubMed ID: 38466799
[TBL] [Abstract][Full Text] [Related]
3. Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.
Randle SJ; Laman H
Curr Protein Pept Sci; 2017; 18(7):715-724. PubMed ID: 26965690
[TBL] [Abstract][Full Text] [Related]
4. Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins.
Nelson DE; Randle SJ; Laman H
Open Biol; 2013 Oct; 3(10):130131. PubMed ID: 24107298
[TBL] [Abstract][Full Text] [Related]
5. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson's disease (PD).
Zhou ZD; Lee JCT; Tan EK
Mutat Res Rev Mutat Res; 2018; 778():72-78. PubMed ID: 30454685
[TBL] [Abstract][Full Text] [Related]
7. The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.
Burchell VS; Nelson DE; Sanchez-Martinez A; Delgado-Camprubi M; Ivatt RM; Pogson JH; Randle SJ; Wray S; Lewis PA; Houlden H; Abramov AY; Hardy J; Wood NW; Whitworth AJ; Laman H; Plun-Favreau H
Nat Neurosci; 2013 Sep; 16(9):1257-65. PubMed ID: 23933751
[TBL] [Abstract][Full Text] [Related]
8. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
[TBL] [Abstract][Full Text] [Related]
9. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J
EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation.
Delgado-Camprubi M; Esteras N; Soutar MP; Plun-Favreau H; Abramov AY
Cell Death Differ; 2017 Jan; 24(1):120-131. PubMed ID: 27689878
[TBL] [Abstract][Full Text] [Related]
11. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
12. Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor.
Kirk R; Laman H; Knowles PP; Murray-Rust J; Lomonosov M; Meziane el K; McDonald NQ
J Biol Chem; 2008 Aug; 283(32):22325-35. PubMed ID: 18495667
[TBL] [Abstract][Full Text] [Related]
13. Impaired mitochondrial accumulation and Lewy pathology in neuron-specific FBXO7-deficient mice.
Noda S; Sato S; Fukuda T; Ueno S; Tada N; Hattori N
Mol Brain; 2022 Jun; 15(1):54. PubMed ID: 35701754
[TBL] [Abstract][Full Text] [Related]
14. E3 ligase adaptor FBXO7 contributes to ubiquitination and proteasomal degradation of SIRT7 and promotes cell death in response to hydrogen peroxide.
Lee SH; Lee YJ; Jung S; Chung KC
J Biol Chem; 2023 Mar; 299(3):102909. PubMed ID: 36646384
[TBL] [Abstract][Full Text] [Related]
15. The parkinsonism-associated protein FBXO7 cooperates with the BAG6 complex in proteasome function and controls the subcellular localization of the complex.
Wang Q; Crnković V; Preisinger C; Stegmüller J
Biochem J; 2021 Jun; 478(12):2179-2199. PubMed ID: 34060591
[TBL] [Abstract][Full Text] [Related]
16. A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.
Fishman-Jacob T; Youdim MBH
J Neural Transm (Vienna); 2024 Jun; 131(6):675-707. PubMed ID: 37644186
[TBL] [Abstract][Full Text] [Related]
17. USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
Lee SH; Chung KC
PLoS One; 2023; 18(10):e0290371. PubMed ID: 37874827
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of FBXO7 and its role in human diseases.
Zhong Y; Li J; Ye M; Jin X
Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
[TBL] [Abstract][Full Text] [Related]
19. FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease.
Chen CM; Chen IC; Huang YC; Juan HF; Chen YL; Chen YC; Lin CH; Lee LC; Lee CM; Lee-Chen GJ; Lai YJ; Wu YR
PLoS One; 2014; 9(7):e101392. PubMed ID: 25029497
[TBL] [Abstract][Full Text] [Related]
20. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
Kang J; Chung KC
Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
